Advertisement

Citation tools

Dimopoulos, Meletios et al "Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR." Blood 133.2 (2019): 147-155. Web. 18 June. 2019.